These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 26315110)

  • 21. Is there a role for adjuvant therapy in resected adenocarcinoma of the small intestine.
    Overman MJ; Kopetz S; Lin E; Abbruzzese JL; Wolff RA
    Acta Oncol; 2010 May; 49(4):474-9. PubMed ID: 20397775
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Do serrated neoplasms of the small intestine represent a distinct entity? Pathological findings and molecular alterations in a series of 13 cases.
    Rosty C; Campbell C; Clendenning M; Bettington M; Buchanan DD; Brown IS
    Histopathology; 2015 Feb; 66(3):333-42. PubMed ID: 24894811
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An overview of adenocarcinoma of the small intestine.
    Neugut AI; Marvin MR; Rella VA; Chabot JA
    Oncology (Williston Park); 1997 Apr; 11(4):529-36; discussion 545, 549-50. PubMed ID: 9130275
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TP53, p14ARF, p16INK4a and H-ras gene molecular analysis in intestinal-type adenocarcinoma of the nasal cavity and paranasal sinuses.
    Perrone F; Oggionni M; Birindelli S; Suardi S; Tabano S; Romano R; Moiraghi ML; Bimbi G; Quattrone P; Cantu G; Pierotti MA; Licitra L; Pilotti S
    Int J Cancer; 2003 Jun; 105(2):196-203. PubMed ID: 12673679
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DNA methyltransferase 1 knockdown induces silenced CDH1 gene reexpression by demethylation of methylated CpG in hepatocellular carcinoma cell line SMMC-7721.
    Fan H; Zhao Z; Quan Y; Xu J; Zhang J; Xie W
    Eur J Gastroenterol Hepatol; 2007 Nov; 19(11):952-61. PubMed ID: 18049164
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic and epigenetic aberrations occurring in colorectal tumors associated with serrated pathway.
    Sakai E; Fukuyo M; Ohata K; Matsusaka K; Doi N; Mano Y; Takane K; Abe H; Yagi K; Matsuhashi N; Fukushima J; Fukayama M; Akagi K; Aburatani H; Nakajima A; Kaneda A
    Int J Cancer; 2016 Apr; 138(7):1634-44. PubMed ID: 26510091
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Retrospective review using targeted deep sequencing reveals mutational differences between gastroesophageal junction and gastric carcinomas.
    Li-Chang HH; Kasaian K; Ng Y; Lum A; Kong E; Lim H; Jones SJ; Huntsman DG; Schaeffer DF; Yip S
    BMC Cancer; 2015 Feb; 15():32. PubMed ID: 25656989
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic Impact of Novel Molecular Subtypes of Small Intestinal Neuroendocrine Tumor.
    Karpathakis A; Dibra H; Pipinikas C; Feber A; Morris T; Francis J; Oukrif D; Mandair D; Pericleous M; Mohmaduvesh M; Serra S; Ogunbiyi O; Novelli M; Luong T; Asa SL; Kulke M; Toumpanakis C; Meyer T; Caplin M; Meyerson M; Beck S; Thirlwell C
    Clin Cancer Res; 2016 Jan; 22(1):250-8. PubMed ID: 26169971
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacologic inhibition of epigenetic modifications, coupled with gene expression profiling, reveals novel targets of aberrant DNA methylation and histone deacetylation in lung cancer.
    Zhong S; Fields CR; Su N; Pan YX; Robertson KD
    Oncogene; 2007 Apr; 26(18):2621-34. PubMed ID: 17043644
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Small bowel tumors: experience at the Instituto Nacional de Ciencias Médicas y Nutrición "Salvador Zubirán"].
    Sánchez-Ramón A; Cerino-Palomino V; Medina-Franco H
    Rev Gastroenterol Mex; 2012; 77(4):181-5. PubMed ID: 23177666
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Promoter methylation of specific genes is associated with the phenotype and progression of colorectal adenocarcinomas.
    Kim JC; Choi JS; Roh SA; Cho DH; Kim TW; Kim YS
    Ann Surg Oncol; 2010 Jul; 17(7):1767-76. PubMed ID: 20077021
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rectal cancer profiling identifies distinct subtypes in India based on age at onset, genetic, epigenetic and clinicopathological characteristics.
    Laskar RS; Ghosh SK; Talukdar FR
    Mol Carcinog; 2015 Dec; 54(12):1786-95. PubMed ID: 25418895
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discovery of novel epigenetic markers in non-Hodgkin's lymphoma.
    Shi H; Guo J; Duff DJ; Rahmatpanah F; Chitima-Matsiga R; Al-Kuhlani M; Taylor KH; Sjahputera O; Andreski M; Wooldridge JE; Caldwell CW
    Carcinogenesis; 2007 Jan; 28(1):60-70. PubMed ID: 16774933
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic and epigenetic analysis of non-small cell lung cancer with NotI-microarrays.
    Dmitriev AA; Kashuba VI; Haraldson K; Senchenko VN; Pavlova TV; Kudryavtseva AV; Anedchenko EA; Krasnov GS; Pronina IV; Loginov VI; Kondratieva TT; Kazubskaya TP; Braga EA; Yenamandra SP; Ignatjev I; Ernberg I; Klein G; Lerman MI; Zabarovsky ER
    Epigenetics; 2012 May; 7(5):502-13. PubMed ID: 22491060
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combined DNA methylation and gene expression profiling in gastrointestinal stromal tumors reveals hypomethylation of SPP1 as an independent prognostic factor.
    Haller F; Zhang JD; Moskalev EA; Braun A; Otto C; Geddert H; Riazalhosseini Y; Ward A; Balwierz A; Schaefer IM; Cameron S; Ghadimi BM; Agaimy A; Fletcher JA; Hoheisel J; Hartmann A; Werner M; Wiemann S; Sahin O
    Int J Cancer; 2015 Mar; 136(5):1013-23. PubMed ID: 25046773
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management of Advanced Small Bowel Cancer.
    Puccini A; Battaglin F; Lenz HJ
    Curr Treat Options Oncol; 2018 Nov; 19(12):69. PubMed ID: 30397729
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Primary adenocarcinoma of the small intestine: presentation, prognostic factors and clinical outcome.
    Hong SH; Koh YH; Rho SY; Byun JH; Oh ST; Im KW; Kim EK; Chang SK
    Jpn J Clin Oncol; 2009 Jan; 39(1):54-61. PubMed ID: 18997182
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical evaluation of panel testing by next-generation sequencing (NGS) for gene mutations in myeloid neoplasms.
    Au CH; Wa A; Ho DN; Chan TL; Ma ES
    Diagn Pathol; 2016 Jan; 11():11. PubMed ID: 26796102
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Frequent inactivation of RAMP2, EFEMP1 and Dutt1 in lung cancer by promoter hypermethylation.
    Yue W; Dacic S; Sun Q; Landreneau R; Guo M; Zhou W; Siegfried JM; Yu J; Zhang L
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4336-44. PubMed ID: 17671114
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions.
    Ruggeri BA; Huang L; Berger D; Chang H; Klein-Szanto AJ; Goodrow T; Wood M; Obara T; Heath CW; Lynch H
    Cancer; 1997 Feb; 79(4):700-16. PubMed ID: 9024708
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.